Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
Study NCT ID:
NCT07039916
Status:
RECRUITING
Last Update Posted:
2025-11-21
First Post:
2025-06-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Sponsor:
Immunovant Sciences GmbH
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Generalized Myasthenia Gravis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | IMVT-1402 | View |
| None | Generalized Myasthenia Gravis | View |
| None | Acetylcholine receptor | View |
| None | Muscle-specific kinase | View |
| None | Autoantibody | View |
| None | Lipoprotein receptor-related protein 4 | View |
| None | Autoimmune disease | View |
| None | Neonatal fragment crystallizable receptor (FcRn) | View |